Alan Schafer to head Population Genetics
07-May-2012
- United Kingdom
Population Genetics Technologies Ltd. has appointed Alan Schafer, PhD to the post of Chief Executive Officer.
Schafer brings deep experience in research, “big pharma” management and building new businesses. He is Adjunct Professor of Innovation at Imperial College London Business School and was previously the Wellcome Trust’s Director of Science Funding. Before that he served as Global Vice-President of Technology Development at GlaxoSmithKline and co-founded Hexagen, a functional genomics company and subsequently acquired by Incyte. He will continue to serve on a number of research and venture capital advisory boards.
Other news from the department people
Most read news
More news from our other portals
Last viewed contents
Rapid imaging of granular matter
Millipore Corporation's re-branding underscores expanded capabilities and partnership with customers - Millipore Foundation awards $500,000 research gift to the Harvard Stem Cell Institute
Molecular motion in tire rubber - Tyre components observed with incredible time resolution
University of Leicester researchers discover new fluorescent silicon nanoparticles - Research may ultimately track the uptake of drugs by the body's cells
Bio-Techne to acquire Quad Technologies
BÜCHI acquires NIR-Online
Opto-electronic nose sniffs out toxic gases
ORNL scientists help explain graphene mystery
Altmann Analytik acquires lab supplier Dinkelberg analytics
New organ-on-chip pilot seeks to reduce animal testing in consumer health industry - Cooperation between Bayer, the start-ups esqLABS and Dynamic42, and Placenta Lab of Jena University Hospital
